GB201212908D0 - Method for the transfer of nanoparticles - Google Patents
Method for the transfer of nanoparticlesInfo
- Publication number
- GB201212908D0 GB201212908D0 GB201212908A GB201212908A GB201212908D0 GB 201212908 D0 GB201212908 D0 GB 201212908D0 GB 201212908 A GB201212908 A GB 201212908A GB 201212908 A GB201212908 A GB 201212908A GB 201212908 D0 GB201212908 D0 GB 201212908D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- nanoparticles
- transfer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201212908A GB2505401A (en) | 2012-08-31 | 2012-08-31 | Transferring nanoparticles into eukaryotic cells |
PCT/EP2013/068002 WO2014033263A1 (en) | 2012-08-31 | 2013-08-30 | Method for the transfer of nanoparticles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201212908A GB2505401A (en) | 2012-08-31 | 2012-08-31 | Transferring nanoparticles into eukaryotic cells |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201212908D0 true GB201212908D0 (en) | 2012-09-05 |
GB2505401A GB2505401A (en) | 2014-03-05 |
Family
ID=46881691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201212908A Withdrawn GB2505401A (en) | 2012-08-31 | 2012-08-31 | Transferring nanoparticles into eukaryotic cells |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2505401A (en) |
WO (1) | WO2014033263A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10961547B2 (en) | 2014-11-05 | 2021-03-30 | Kansas State University Research Foundation | Multifunctional metallic nanoparticle-peptide bilayer complexes |
US10857388B2 (en) | 2016-12-16 | 2020-12-08 | Carl Zeiss Meditec Ag | Radiation therapy with immune response monitoring |
CN111991561A (en) * | 2020-08-26 | 2020-11-27 | 中国科学院上海高等研究院 | Oligonucleotide/atom fine nanocluster compound capable of efficiently penetrating blood brain barrier and preparation method and application thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6361944B1 (en) * | 1996-07-29 | 2002-03-26 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
CA2572865C (en) * | 2004-07-09 | 2017-07-25 | Robert Sabin | Compositions and methods of use for treatment of mammalian diseases |
US7625702B2 (en) * | 2005-12-20 | 2009-12-01 | International Business Machines Corporation | Helical wrapping of single-walled carbon nanotubes by genomic DNA |
JP5271715B2 (en) * | 2006-11-22 | 2013-08-21 | 国立大学法人 東京大学 | Environmentally responsive siRNA carrier using disulfide crosslinked polymer micelle |
US20110052671A1 (en) * | 2008-01-30 | 2011-03-03 | The Regents Of The University Of California | Near infra-red pulsed laser triggered drug release from hollow nanoshell disrupted vesicles and vesosomes |
US20100075314A1 (en) * | 2008-05-23 | 2010-03-25 | Viswanadham Garimella | Chemically-modified gold nanoparticles and methods for use in detecting target molecules |
KR101170473B1 (en) * | 2008-09-05 | 2012-08-01 | 서울대학교산학협력단 | Novel lipid-gold nanoparticle hybrid, and gene delivery method using the same |
US20130029360A1 (en) * | 2009-12-11 | 2013-01-31 | Snu R&Db Foundation | Dimeric core-shell nanostructure labeled with raman active molecule localized at interparticle junction, use thereof, and method for preparing the same |
JP2013529677A (en) * | 2010-06-29 | 2013-07-22 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Synthesis of high performance iron oxide particle tracer for magnetic particle imaging (MPI) |
-
2012
- 2012-08-31 GB GB201212908A patent/GB2505401A/en not_active Withdrawn
-
2013
- 2013-08-30 WO PCT/EP2013/068002 patent/WO2014033263A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
GB2505401A (en) | 2014-03-05 |
WO2014033263A1 (en) | 2014-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2833926A4 (en) | Neurophilic nanoparticles | |
GB201223172D0 (en) | Method | |
GB201503017D0 (en) | Method and system for the production of nanoparticles | |
GB201212937D0 (en) | Method | |
EP2939754A4 (en) | Draw forming method | |
GB201212932D0 (en) | Method | |
PL2817775T3 (en) | Audience-measuring method | |
GB201213636D0 (en) | Method | |
GB201212934D0 (en) | Method | |
GB201210858D0 (en) | Method | |
SG11201407032WA (en) | Method | |
GB201216930D0 (en) | Nanoparticles | |
EP2880048A4 (en) | Method | |
GB201218570D0 (en) | Method | |
GB201202198D0 (en) | Method | |
GB201212908D0 (en) | Method for the transfer of nanoparticles | |
GB201211393D0 (en) | Method | |
GB201209517D0 (en) | Nanoparticles | |
GB201223316D0 (en) | Method | |
GB201222737D0 (en) | Method | |
GB201217688D0 (en) | Method | |
GB201214029D0 (en) | method | |
GB201215942D0 (en) | Method of treatent | |
GB201210147D0 (en) | Method | |
ZA201504218B (en) | Method for carrying out transactions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |